期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | EBioMedicine LetPub Score 7.6
50 ratings
Rate
Reputation 8.4 Influence 6.9 Speed 7.2 | ||||||||||||||||||||
期刊簡稱 | EBIOMEDICINE | ||||||||||||||||||||
ISSN | 2352-3964 | ||||||||||||||||||||
h-index | 37 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 1.00%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.ebiomedicine.com/ | ||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/EBIOM | ||||||||||||||||||||
開放訪問 | Yes | ||||||||||||||||||||
出版商 | Elsevier BV | ||||||||||||||||||||
主題領域 | Biochemistry, Genetics and Molecular Biology | ||||||||||||||||||||
出版國/地區 | Netherlands | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 429每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 77.56% | ||||||||||||||||||||
OA Related Info | APC: Yes( USD5000; ) APC waiver:Check Notes Other charges: No Keywords: basic science、clinical science、translational、genetics、drug targeting、biomedicine Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2352-3964%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: 5 Weeks | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[EBioMedicine] 的評論 | 撰寫評論 |
作者: 冰心永军 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-27 17:02:51 評論於 Foreknowledge is a real thing(0) 讚! | 冰心永军 |
作者: 杨家翠柏 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-09 21:53:31 評論於 Feeling lucky!(0) 讚! | 杨家翠柏 |
作者: 东风春风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-04-08 23:41:54 評論於 Review speed: 2.0 Experience sharing: This magazine is really not simple. The three reviewers are all very strict, and it's tough(0) 讚! | 东风春风 |
作者: 神经组织工程 領域: 医学 審稿時間: 2.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-04-01 19:40:13 評論於 2023.12.11 submitted 2023.12.12 ur (out for review) 2023.12.28 ur 2023.12.29 ur 2023.12.30 rrc 2024.1.2 ur 2024.1.9 ur 2024.1.28 rrc 2024.2.2 revise (4 reviewers) 2024.3.1 revision submitted 2024.3.3 ur 2024.3.5 rrc 2024.3.7 rrc 2024.3.19 rrc 2024.3.20 revise (3 reviewers ok for publication, 1 reviewer has minor statistical concern) 2024.3.26 revision submitted 2024.3.31 accepted(0) 讚! | 神经组织工程 |
作者: 乐安小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-28 16:14:10 評論於 Review speed: 1.0 | Submission acceptance rate: 50.0 Experience sharing: After Christmas, the manuscript may actually only take three weeks to return(0) 讚! | 乐安小可爱 |
作者: 东风春风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-03-16 16:14:49 評論於 Hello, may I ask if there is any update now? I also changed from "required reviewers completed" to "under review" 2 days later, and these two days were weekends. What does it mean when the status changes like this for the first review?(0) 讚! | 东风春风 |
作者: 独孤千灵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-26 22:05:56 評論於 My just required reviews completed have reverted to under review again after 3 days. Have you heard any news?(0) 讚! | 独孤千灵 |
作者: 乌龙铃语 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-02-19 17:05:01 評論於 I am also like this(0) 讚! | 乌龙铃语 |
作者: 仲夏宇寰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-28 21:04:45 評論於 I wonder why "required reviews completed" changed to "under review" the next day(0) 讚! | 仲夏宇寰 |
作者: 仲夏宇寰 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-01-17 08:41:12 評論於 Heavy research direction: translational medicine sharing experience: After submission, it became under review in 3 days, with two date changes in the middle, but it is still in the under review status. What could be the reason for this?(0) 讚! | 仲夏宇寰 |
作者: 平原摄提格 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-14 23:11:18 評論於 I will send an email to the editorial department. Each person's situation is different(0) 讚! | 平原摄提格 |
作者: 一条小思嫒 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-12-02 16:50:42 評論於 Hey guys, I just wanted to ask how long it usually takes for the step "Required Reviews Completed" in this magazine. It's been almost a month and there hasn't been any progress(0) 讚! | 一条小思嫒 |
作者: 留云弘雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-21 21:38:25 評論於 Being able to send for review shows that the quality and originality of the article are quite good(0) 讚! | 留云弘雅 |
作者: 留云弘雅 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-21 12:27:03 評論於 Mediocre articles are basically not submitted for review, this magazine is quite picky now(0) 讚! | 留云弘雅 |
作者: Merry Roy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-16 13:01:31 評論於 How long has it been in the "with editor" status?(0) 讚! | Merry Roy |
作者: 碧水雪风 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-11-05 09:50:03 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Research focus: Microecology Experience sharing: Submitted on June 28th, reviewed in two months. Status changed once in the middle, then back to "under review". Given one month for major revisions, returned for re-evaluation on October 9th(0) 讚! | 碧水雪风 |
作者: 李拜天。 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-23 10:35:06 評論於 I would like to ask, does the first author have to be the owner of the submission account when submitting a manuscript? Can the authors' order be changed? Why can't I find where to do this?(0) 讚! | 李拜天。 |
作者: 昆娜沃尔特 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-24 09:05:54 評論於 Research Focus: Translational Medicine Experience Sharing: Three Days of Rejections(0) 讚! | 昆娜沃尔特 |
作者: 天神院梦凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-15 15:40:20 評論於 The mainstream media in the Netherlands and Belgium have fully covered the scientific progress of our COVID-19 research on their front pages: de Volkskrant in the Netherlands: https://www.volkskrant.nl/wetenschap/een-leven-zonder-postcovid-ietsje-dichterbij-amsterdamse-wetenschappers-zitten-op-een-spoor~ba477769/ and the largest newspaper in Belgium, Het Nieuwsblad: https://www.nieuwsblad.be/cnt/dmf20230811_93098420?&articlehash=MkRUxwabcfJ8bfDLtOaVWo7jwbZ98Fjdhc17YhipVT%2BJG2ewmboDCFv2bPfI7eSyC7SSrJoOP3jjQ48jjZz6iIGMQm6Wcm%2FS6KmLKbJ%2B4C9OXC%2FtTlRdKM4QNFBf6610IXzxOOK07HR7N0cNNkNdQD50FmjJnV1EejaVFpkVZcU%2FciMBWRkN%2BY15227Z1Mt3N%2FI6XvlCn%2FPVZn%2Bm%2FWOSogyIJ1speTRBaR0pxjr9EOV4HVfPfvvlcelh3Xm1qzkTD8bKkPuYMPBCTsLJ2HZ1Dv6z95rRtUJb3%2FvoIEgAtV5PUuFoz1JF3T5UUcAppywmhBZmaPG6sVlzeCqH3nwK0Q%3D%3D(0) 讚! | 天神院梦凝 |
作者: 震雷鑫鑫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-16 15:47:48 評論於 Please translate the following paragraph into English and Japanese, and title them as ":" and ":"(0) 讚! | 震雷鑫鑫 |
作者: 天神院梦凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-12 13:35:49 評論於 Our research on PASC, long COVID-19, after 9-10 months of work and two rounds of revision, has just been accepted. Happy! Next step is clinical translation and application(0) 讚! | 天神院梦凝 |
作者: 天神院梦凝 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-11 22:40:22 評論於 Review speed: 12.0 | Submission acceptance rate: 5.0 Experience sharing: PASC, long COVID-19, review for 9-10 months, really heart-wrenching, but it feels worth it when receiving the acceptance email, the more difficult the peer review, the more I like it(0) 讚! | 天神院梦凝 |
作者: Wilbur Salome 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-05-26 16:18:01 評論於 Vancouver format, you can simply search and download(0) 讚! | Wilbur Salome |
作者: Horace MacMillan 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-26 15:52:59 評論於 Sending for external audit(0) 讚! | Horace MacMillan |
作者: 西域碧菡 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-04-22 11:07:47 評論於 Is it under review the next day after submission? Is it sent for external review or is the editor reviewing it?(0) 讚! | 西域碧菡 |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us